Family Medicine

Learning Objectives

• Apply current evidence-based recommendations for the diagnosis, management, and prevention of emerging infectious diseases relevant to family medicine, including tick-borne illnesses and measles
• Identify appropriate candidates for new and evolving therapies in primary care, including teplizumab for delaying progression to clinical type 1 diabetes and updated guideline-directed asthma management
• Integrate recent clinical guideline updates and landmark evidence into everyday family medicine practice to improve patient care and health outcomes

Speakers

JS

Jennifer Shuey, DO

Learning Objectives

• Describe the diagnostic criteria and clinical presentation of perimenopause and menopause, including the hormonal and physiological changes that distinguish these transitions from other conditions in the differential
• Identify evidence-based candidates for hormone replacement therapy based on current guidelines, symptom presentation, and individual risk factors, including contraindications requiring further workup or specialist referral
• Apply evidence-based prescribing strategies for hormone replacement therapy, including formulation and route selection, to safely initiate or manage treatment in a family medicine setting

Speakers

RH

Rebecca Hertel, DO, MSCP

Learning Objectives

• Define major FoodRx program models and discuss promising findings and important limitations
• Explain how policy, payment, and public-private-partnerships can move FoodRx initiatives from pilot to sustainable programs
• Use the physician prescription pad as a powerful FoodRX policy and advocacy tool

Learning Objectives

• Differentiate uncomplicated UTI (uUTI) from asymptomatic bacteriuria, complicated UTI (cUTI), and pyelonephritis using current evidence-based guideline criteria
• Select evidence-based, guideline-concordant, treatment regimens, including novel agents, for uUTI, considering local resistance patterns and antimicrobial stewardship principles
• Apply risk-based stratification for uUTIto optimize therapy or determine when to obtain urine cultures
• Develop patient-centered strategies that reduce the multifaceted burden of uUTIs on patients and the healthcare system, promoting holistic management and improved outcomes

Speakers

Learning Objectives

• Describe what constitutes a peptide
• Evaluate which peptides are currently legal to prescribe
• Summarize the evolving landscape of peptides

Speakers

Learning Objectives

• Recognize the opportunity to incorporate osteopathic evaluation and treatment to common FM complaints
• Recall autonomic nervous system, lymphatic, and biomechanical applications to common FM complaints
• Practice utilizing coding and billing for OMT in a busy office setting
• Overcome barriers to utilizing OMT in your practice

Speakers

DM

David Mason, DO, MBA, FACOFP

Learning Objectives

• Review updates published withing the contents of the The Preparticipation Physical Evaluation (PPE) Monograph, 6th Edition
• Review risk of pre-existing conditions or hidden medical issues (cardiac or structural abnormalities)
• Summarize eligibility criteria within medical clearance and recommend appropriate sports-specific accommodations or restrictions
• Focus on injury prevention, evaluation, and addressing risk factors for orthopedic injuries
• Promote wellness and address general health topics, including mental health, nutrition, and safe lifestyle behaviors

Speakers

Speakers

Speakers

Learning Objectives

• Recognize the clinical significance of elevated Lp(a) as an independent, genetically determined CV risk factor to support patient understanding and shared decision making
• Determine appropriate use of Lp(a) test, including universal once-in-a-lifetime testing and targeted testing of high-risk individuals
• Incorporate Lp(a) testing into CV risk assessment, despite the absence of currently approved Lp(a)-lowering therapies
• Develop treatment and referral strategies for patients with elevated Lp(a) by optimizing CV risk reduction and coordinating care with appropriate specialists

Learning Objectives

• Compare the mechanisms and pharmacokinetic/pharmacodynamic properties of once weekly and once daily basal insulins to anticipate their potential clinical use
• Interpret the efficacy and safety data for emerging once weekly basal insulins and apply this knowledge to anticipate their potential role in managing type 2 diabetes
• Develop individualized evidence-based treatment plans for patients with type 2 diabetes who require basal insulin that incorporates best practices for initiation, dosing, and titration

Speakers

KP

Kimberly Pfotenhauer, DO

CW

Carol Wysham, MD

Learning Objectives

• Discuss the importance of diagnosing obstructive sleep apnea (OSA), including its relationship to disease-associated complications
• Screen patients for and diagnose OSA using evidence-based guideline recommendations
• Develop guideline-directed obesity management plans for patients with OSA as part of an evidence-based OSA treatment strategy
• Monitor treatment for OSA and modify therapy, as appropriate

Speakers

NP

Nicholas Pennings, DO

Learning Objectives

• Recognize the major categories of neurodivergence encountered in a primary care practice
• Individualize ADHD pharmacotherapy treatment for neurodivergent patients
• Explain why screening and treating ADHD in all children and caregivers improves outcomes for the whole family

Speakers

RB

Ranelle Bracy-Lewis, DO

Speakers

JW

Jacqueline Watson, DO, MBA

Learning Objectives

• Effectively communicate with patients the medical rationale for treating obesity as a chronic disease requiring long-term care
• Develop a structured approach to establishing obesity management plans with patients
• Select appropriate assessment tools for use in treatment plans for patients who are overweight or obese
• Apply evidence-based dose titration protocols and side effect management strategies to the care plan for a patient who is overweight or obese and who is utilizing anti-obesity medications
• Design a long-term management plan for patients who are overweight or obese and who have achieved initial weight loss goals

Speakers

KP

Kimberly Pfotenhauer, DO

Learning Objectives

• Critically appraise the evidence supporting current and emerging pharmacologic and procedural therapies for obesity, with emphasis on GLP-1 receptor agonists therapies
• Recognize and manage the common, serious, and emerging adverse effects of GLP-1–based therapies, incorporating patient-specific risk factors into clinical decision-making
• Identify barriers to effective obesity treatment—including medication access, adherence, cost, and healthcare disparities—and develop practical strategies to improve equitable patient care

Speakers

AB

Andrew Buelt, DO

Speakers

Speakers

Learning Objectives

• Describe the changing nutritional requirements across key stages of life, including infancy, childhood, adolescence, adulthood, pregnancy, and older adulthood
• Identify nutrition-related risk factors that contribute to chronic disease development throughout the lifespan
• Apply evidence-based nutrition recommendations to support growth, health maintenance, and healthy aging in diverse patient populations

Speakers

Learning Objectives

• Differentiate insomnia, OSA, restless legs syndrome, and central disorders of hypersomnolence using targeted history, screening tools, and clue-based diagnostic reasoning
• Develop an initial, symptom-based diagnostic approach that incorporates indications for sleep studies (PSG, HST), ferritin testing, and other relevant workup in primary care
• Apply appropriate first-line ACTION steps for insomnia, RLS, OSA, and hypersomnolence disorders that can be safely initiated and monitored in primary care
• Identify red flags and clinical scenarios that warrant timely referral to a sleep center or sleep specialist for advanced evaluation and management

Speakers

PG

Philip Gehrman, PhD, CBSM, FAASM

AM

Atul Malhotra, MD, FAASM

AM

Anne Marie Morse, DO, FAASM

Learning Objectives

• Describe the risk factors and assessment for obstructive sleep apnea (OSA) and based on pathophysiology, clinical features, and common comorbidities to guide appropriate management
• Select evidence-based diagnostic pathways for suspected OSA, including when to order home sleep testing vs. in-lab polysomnography, based on patient symptoms, risk factors, and complexity
• Initiate and adjust first-line treatment strategies in primary care for patients with uncomplicated OSA and obesity-related sleep-disordered breathing
• Identify and manage patients who require advanced or specialized therapies and coordinate timely referral to sleep centers or specialty care for complex or refractory cases

Speakers

AM

Atul Malhotra, MD, FAASM

AM

Anne Marie Morse, DO, FAASM

Learning Objectives

• Differentiate common causes of excessive daytime sleepiness and recognize key clinical features of idiopathic hypersomnia (IH) and narcolepsy in the primary care setting
• Initiate an evidence-based primary care workup for patients with excessive daytime sleepiness prior to referral
• Identify patients who require referral to a sleep center for full evaluation of IH or narcolepsy and prepare them for accurate testing

Speakers

AM

Anne Marie Morse, DO, FAASM

AM

Atul Malhotra, MD, FAASM

Speakers

KP

Kimberly Pfotenhauer, DO

Speakers